Cohance Lifesciences Limited
COHANCE
Rang in Aktien
#6361
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Aktienkurs
$5.06
Zuletzt synchronisiert: 2026-10-19
Marktkapitalisierung
$1.93B
Veränderung (1 Tag)
-1.34%
Veränderung (1 Jahr)
-57.33%
Land
IN
Handel Cohance Lifesciences Limited (COHANCE)
Kategorie
Healthcare
Dividendenhistorie für Cohance Lifesciences Limited (COHANCE)
Cohance Lifesciences Limited (Aktienkürzel: COHANCE) zahlte insgesamt 5 Dividenden.
Die Summe aller Dividenden (angepasst an Aktiensplits) beträgt: $10.00
Dividendenrendite (TTM): 0
Die Summe aller Dividenden (angepasst an Aktiensplits) beträgt: $10.00
Dividendenrendite (TTM): 0
Dividendenzahlungen für Cohance Lifesciences Limited (COHANCE) von 2021 bis 2026
Jährliche Dividendenzahlungen
| Jahr | Dividende (angepasst an Aktiensplits) | ändert |
|---|---|---|
| 2026 (TTM) | $5.00 | -37.50% |
| 2022 | $8.00 | 300.00% |
| 2021 | $2.00 | 0.00% |
Liste aller Dividendenzahlungen
| Jahr | Dividende | ändert |
|---|---|---|
| 2026 (TTM) | $5.00 | -37.50% |
| 2022 | $8.00 | 300.00% |
| 2021 | $2.00 | 0.00% |
Dividendenzahlungen ähnlicher Unternehmen oder Wettbewerber
| Unternehmen | Anzahl der Dividendenzahlungen | Land |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 38.00% |
IN
|
